Mdxhealth SA 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
MDxHealth SA details executive severance agreement terms and reports annual financial results, highlighting strategic shifts and risk factors.
NASDAQ
MDxHealth defers earn-out payments, increases potential consideration, and gains access to additional capital through an amended agreement with Genomic Health.